Skip to main content

Emrelis Side Effects

Generic name: telisotuzumab vedotin

Note: This document provides detailed information about Emrelis Side Effects associated with telisotuzumab vedotin. Some dosage forms listed on this page may not apply specifically to the brand name Emrelis.

Applies to telisotuzumab vedotin: intravenous powder for injection.

Important warnings This medicine can cause some serious health issues

Telisotuzumab vedotin can cause severe and life-threatening side effects after the injection.

Call your doctor right away if you have numbness, tingling, or burning pain in your hands or feet, blurred vision, eye pain or redness, fever, cough, feeling short of breath, or you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache.

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Telisotuzumab vedotin (the active ingredient contained in Emrelis) can cause severe and life-threatening side effects. Call your doctor right away if you have numbness, tingling, muscle weakness, or burning pain in your hands or feet, blurred vision, eye pain, swelling, or redness, increased sensitivity to light, fever, cough, wheezing, or feeling short of breath.

Some side effects may occur during the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to telisotuzumab vedotin: intravenous powder for injection.

General adverse events

The most frequently reported side effects were decreased appetite, fatigue, peripheral edema, and peripheral neuropathy. The most frequently reported grade 3 or 4 laboratory abnormalities were decreased calcium, decreased hemoglobin, decreased lymphocytes, decreased phosphorus, decreased sodium, increased ALT, increased glucose, and increased GGT.[Ref]

Cardiovascular

Gastrointestinal

Hematologic

Hepatic

Immunologic

Metabolic

Musculoskeletal

Nervous system

Ocular

Blurred vision included blurred vision, reduced visual acuity, and visual impairment.

Keratitis included corneal cyst, corneal disorder, corneal erosion, corneal edema, corneal opacity, keratitis, interstitial keratitis, and punctate keratitis.[Ref]

Other

Renal

Respiratory

References

1. (2025) "Product Information. Emrelis (telisotuzumab vedotin)." AbbVie US LLC

Does Emrelis interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Further information

Emrelis side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.